Commure
PrivateLast Round
VC Round
May 19, 2026
Est. Valuation
$7B
Total Funding Raised
$1B
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Commure is a healthcare technology company that provides an AI-native enterprise platform for health systems, integrating ambient intelligence, agentic AI, and revenue cycle automation to streamline clinical and operational workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Revenue Cycle, EHR & EMR, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Commure Comparables
Compare Commure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambience Healthcare | 87% | |
| Abridge Inc | 87% | |
| Notable | 82% |
Commure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 19, 2026 | ||||
| Growth Equity | Jun 19, 2025 | ||||
| M&A | Oct 4, 2023 | ||||
| Series C | Sep 16, 2021 | ||||
| Series D | Sep 16, 2021 | ||||
Series B | Apr 26, 2019 |
Key People
Founding team and executive leadership
Commure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series D |
| Greenoaks Capital Partners | Series D |
| Morgan Stanley | VC Round |
| Sequoia Capital | VC Round |
| General Catalyst | Series D, Series C, M&A, Series A, VC Round, Growth Equity |
| FJ Labs | Series A |
| Quiet Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$70M round led by General Catalyst.
- May 16, 2026
Platform now supports over 100 million patient interactions.
Recent news
Latest coverage and updates
- partners_withOct 13, 2026
Commure partners with Compassus to bring AI-powered referral automation to home-based care in California on Oct 13th '26
- recognized_asSep 17, 2026
Commure recognized as World's Top HealthTech Companies for 2026 on Sep 17th '26.
- receives_awardJul 23, 2026
Tanay Tandon at Commure received award Gold for Company of the Year in Healthcare Technology on Jul 23rd '26.
- receives_awardJul 23, 2026
Commure received award two 2026 Stevie(R) Awards for Technology Excellence on Jul 23rd '26.
- launchesJul 20, 2026
Commure launched AI-native referral management and intake platform on Jul 1st '26.
Commure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Commure's valuation, stock price, and market status.
Is Commure a public or private company?
Commure is a private company.
What is the current stock price of Commure?
Commure is a private company, so its shares have no public market price. Caplight tracks Commure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Commure worth (valuation)?
Commure's valuation is estimated at $7.0B based on funding round data.
Can I buy Commure stock?
Commure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Commure's last funding round?
Commure's most recent funding round was VC Round on May 19, 2026.
Who are the main investors in Commure?
Key investors in Commure include Human Capital, Greenoaks Capital Partners, General Catalyst.
Will Commure IPO soon?
No public IPO plans have been announced for Commure.
How can I track Commure secondary market activity?
Caplight tracks bids, offers, and trades in Commure's shares on secondary markets.